Stock screenerAll disclosures →
EDGAR →
MYGN
Conviction 53HealthcareScan · Thu, Jun 25, 2026MYGN$5.42+3.74%
ResistanceSupportVol 14Insider buyInsider sellVol MA14 1.49M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price5.42
Change+3.74%
Gap+0.77%
Rel volume1.77×
Avg volume1.84M
Avg $ vol8.25M
SMA 204.50
SMA 504.44
SMA 2005.83
Price vs 50+21.87%
Price vs 200-7.08%
MA stackmixed
50/200 cross—
Supertrendup · 4.44
RSI (14)70
MACD hist0.10
MACD cross—
Stoch %K / %D93 / 89
ADX (14)24
+DI / −DI37 / 10
RSI divergence—
MACD divergence—
ATR %+5.62%
ADR %7.07%
52w high8.18
52w low3.55
From 52w high-33.80%
Above 52w low+52.54%
New 52w highNo
SqueezeOff
Bollinger width28.40%
%B1.22
Donchian pos94.24%
Donchian high5.51
Donchian low3.86
AVWAP (52w high)5.26
vs AVWAP high+2.95%
AVWAP (52w low)4.33
vs AVWAP low+24.96%
OBV trendUp
Chaikin MF (20)0.10
Today vs 20d1.77×
Avg vol (14d)1.49M
Avg vol (20d)1.84M
Avg $ vol (20d)8.25M
Market cap511.44M
RS 3m (vs SPY)+0.98%
RS 6m (vs SPY)-28.04%
RS line new highNo
Trend template3/8
Technical rank51.6
1 week+23.63%
1 month+40.65%
3 months+15.71%
6 months-19.90%
1 year+7.23%
YTD-11.81%
P/E-1.40
P/B1.52
P/S0.62
P/FCF-11.76
EPS-3.95
Div yield—
ROE-108.45%
ROA-54.31%
Debt/Eq0.53
Current2.40
EV/EBITDA-1.50
Gross margin69.93%
Net margin-44.38%
Rev growth-1.56%
EPS growth-187.43%
Price target7.50
Target upside38.50%
Analyst ratingBuy
Institutional105.23%
Ent. value566.74M
Revenue200.4M
Net income-34.1M
Gross profit137.6M
Free cash flow-43.5M
IndustryIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
ExchangeNasdaq
Shares out94.45M
Employees2.7K
ListedFri, Oct 6, 1995
Free float89.75M
Float %96.0%
Short interest8.55M
Days to cover4.2d
Short volume30.1%
Squeeze score52 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast−$0.08 · 1 est
Last EPS vs est−$0.16 vs −$0.16
Last surprise0.0% beat
Setup gradeC
Conviction53 / 100
Pattern quality—
Tech rank51.6 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance4.92
Support3.64
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in MYGN
No recent disclosed trades by Congress in MYGN. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in MYGN · 9 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Kumar Rashmi Director · Common Stock · 2026-06-08 | Sell | 15K | $67K | 2026-06-08 | 2026-06-09 |
Dreismann Heinrich Director · Common Stock · 2026-06-04 | Grant | 59.7K | $0 | 2026-06-04 | 2026-06-05 |
Bisaro Paul Director · Common Stock · 2026-06-04 | Grant | 59.7K | $0 | 2026-06-04 | 2026-06-05 |
Newcomer Lee Nisley Director · Common Stock · 2026-06-04 | Grant | 59.7K | $0 | 2026-06-04 | 2026-06-05 |
Davis Mark Steven Director · Common Stock · 2026-06-04 | Grant | 59.7K | $0 | 2026-06-04 | 2026-06-05 |
Phanstiel S. Louise Director · Common Stock · 2026-06-04 | Grant | 59.7K | $0 | 2026-06-04 | 2026-06-05 |
Kumar Rashmi Director · Common Stock · 2026-06-04 | Grant | 59.7K | $0 | 2026-06-04 | 2026-06-05 |
Reitan Colleen F Director · Common Stock · 2026-06-04 | Grant | 59.7K | $0 | 2026-06-04 | 2026-06-05 |
Skovronsky Daniel Director · Common Stock · 2026-06-04 | Grant | 59.7K | $0 | 2026-06-04 | 2026-06-05 |
Jampa Raj Chief Technology Officer · Common Stock · 2026-06-01 | Grant | 251.89K | $0 | 2026-06-01 | 2026-06-02 |
SEC filings
EDGAR filings in MYGN · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.